Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1980-7-28
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0090-0036
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
473
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:7377416-Drug Compounding,
pubmed-meshheading:7377416-Drug Labeling,
pubmed-meshheading:7377416-Drug Prescriptions,
pubmed-meshheading:7377416-Fees, Pharmaceutical,
pubmed-meshheading:7377416-Humans,
pubmed-meshheading:7377416-Legislation, Drug,
pubmed-meshheading:7377416-Prescription Fees,
pubmed-meshheading:7377416-United States
|
pubmed:year |
1980
|
pubmed:articleTitle |
The irony of drug product selection.
|
pubmed:publicationType |
Journal Article
|